You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Polycythemia Vera

Showing 26 - 50 of 416
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), Post-Essential Thrombocythemia Myelofibrosis

Terminated
  • Primary Myelofibrosis (PMF)
  • +2 more
  • Larkspur, California
  • +2 more
Nov 14, 2022

Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, ET-MF Trial in New York (Canakinumab)

Recruiting
  • Primary Myelofibrosis
  • +4 more
  • New York, New York
    Ruttenberg Treatment Center
Jul 18, 2022

Polycythemia Vera Trial in Korea, Republic of, Malaysia (PTG-300)

Active, not recruiting
  • Polycythemia Vera
  • Incheon, Korea, Republic of
  • +7 more
Mar 8, 2022

Effect of Phlebotomy on Heartrate in Polycythemia Patients

Not yet recruiting
  • Polycythemia
  • phlebotomy
  • (no location specified)
Jun 2, 2022

Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera

Completed
  • Adherence, Patient
  • Adherence, Treatment
    • Cosenza, Calabria, Italy
    • +27 more
    Oct 11, 2023

    Polycythemia Vera Trial in India, United States (PTG-300, Placebo)

    Active, not recruiting
    • Polycythemia Vera
    • Phoenix, Arizona
    • +15 more
    Apr 12, 2022

    Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in United States

    Completed
    Has Results
    • Primary Myelofibrosis
    • +2 more
    • Scottsdale, Arizona
    • +8 more
    Feb 10, 2022

    Myelofibrosis Trial (Momelotinib)

    Available
    • Myelofibrosis
    • (no location specified)
    Oct 12, 2022

    Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Ipoh (NS-018,

    Recruiting
    • Primary Myelofibrosis
    • +2 more
    • Worcester, Massachusetts
    • +16 more
    Oct 31, 2022

    Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia, Polycythemia Vera Trial in Houston (Imatinib Mesylate (Gleevec))

    Completed
    Has Results
    • Chronic Myelomonocytic Leukemia
    • +4 more
    • Imatinib Mesylate (Gleevec)
    • Houston, Texas
      UT MD Anderson Cancer Center
    Dec 7, 2021

    Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Los Angeles

    Not yet recruiting
    • Clonal Cytopenia of Undetermined Significance
    • +4 more
    • Biospecimen Collection
    • +6 more
    • Los Angeles, California
    • +1 more
    Oct 4, 2023

    Polycythemia Vera (PV) Trial in Japan (P1101 (Ropeginterferon alfa-2b))

    Recruiting
    • Polycythemia Vera (PV)
    • P1101 (Ropeginterferon alfa-2b)
    • Toon-shi, Ehime, Japan
    • +5 more
    Jun 13, 2022

    Myelofibrosis; Anemia, Anemia, Myelofibrosis Trial in Canton, Gettysburg (DISC-0974)

    Recruiting
    • Myelofibrosis; Anemia
    • +5 more
    • Jacksonville, Florida
    • +6 more
    Jan 3, 2023

    Myelodysplastic/Myeloproliferative Tumor, Unclassifiable, Myelofibrosis Transformation in Essential Thrombocythemia,

    Recruiting
    • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 18, 2022

    Polycythemia Vera Trial in London, Oxford (Ruxolitinib, Hydroxycarbamide, Interferon-Alpha)

    Recruiting
    • Polycythemia Vera
    • London, United Kingdom
    • +1 more
    Nov 29, 2021

    Polycythemia Vera Trial in Worldwide (Placebo, Rusfertide)

    Recruiting
    • Polycythemia Vera
    • Fresno, California
    • +34 more
    Jul 28, 2022

    Polycythemia Vera (PV) Trial in Japan (P1101, Low-dose aspirin, Phlebotomy)

    Completed
    • Polycythemia Vera (PV)
    • Toon-shi, Ehime, Japan
    • +7 more
    Dec 8, 2021

    Polycythemia Vera Trial in China (Ropeginterferon alfa-2b)

    Active, not recruiting
    • Polycythemia Vera
    • Ropeginterferon alfa-2b
    • Beijing, China
    • +13 more
    Aug 1, 2022

    Primary Myelofibrosis Trial in Japan (Fedratinib)

    Recruiting
    • Primary Myelofibrosis
    • Suwa, Nagano, Japan
    • +25 more
    Jan 18, 2023

    Essential Thrombocythemia, Polycythemia Vera, Primary Myelofibrosis Trial in Buffalo (drug, dietary supplement, other)

    Terminated
    • Essential Thrombocythemia
    • +2 more
    • Arsenic Trioxide
    • +3 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Jul 20, 2022

    Polycythemia Vera Trial in Worldwide (Idasanutlin)

    Terminated
    Has Results
    • Polycythemia Vera
    • Phoenix, Arizona
    • +10 more
    Dec 7, 2021

    Acute Myeloid Leukemia, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Seattle (Decitabine, Ruxolitinib,

    Recruiting
    • Acute Myeloid Leukemia
    • +8 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 18, 2022

    Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Small Lymphocytic Lymphoma Trial in Baltimore (Fludarabine,

    Completed
    Has Results
    • Myelodysplastic Syndrome
    • +13 more
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Nov 2, 2022

    Primary Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia Trial in Toronto (Observational)

    Recruiting
    • Primary Myelofibrosis
    • +9 more
    • Observational
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Apr 11, 2022

    Myelofibrosis, Post-polycythemia Vera Myelofibrosis (PPV-MF), Post-essential Thrombocythemia Myelofibrosis (PET-MF) Trial in

    Completed
    • Myelofibrosis
    • +3 more
    • Ann Arbor, Michigan
    • +4 more
    Mar 28, 2022